Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Abbott Laboratories (NY: ABT)
37.48 USD  -0.24 (-0.64%)
Official Closing Price  /  Updated: 6:40 PM EDT, May 23, 2013  /  Add to My Watchlist      
View: Quote News Research
Stories about Abbott Laboratories
 
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
BofA/Merrill Removes Five from High Quality & Dividend Yield Screen (TIF) (ABBV)
February 01, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8051820 for the full story. Read More
from StreetInsider.com News Articles
Roche Holdings’s Oncology, Virology Drugs Drive Growth
February 01, 2013
category Pharmaceuticals
from Trefis
Abbott Laboratories - Market Review
February 01, 2013
NEW YORK (AVAFIN) -- Financial institutions traded 44 block trades on shares of Abbott ... Read More
from AVAFIN
UPDATE 1-FTC chairman Leibowitz to step down in February
January 31, 2013
WASHINGTON, Jan 31 (Reuters) - The chairman of the Federal Trade Commission, Jon Leibowitz, said on Thursday he will step down in mid-February after a tenure famous for a probe of allegations that... Read More
category companyNews
from Reuters: Company News
Merck Earnings Preview: What We Are Watching
January 31, 2013
category Pharmaceuticals
from Trefis
Boston Scientific Revised To $8 On Acquisitions, New Products & Cost Cutting Efforts
January 31, 2013
category Pharmaceuticals , Medical Devices & Supplies
from Trefis
Pfizer’s Emerging Markets Growth And Newer Drugs Mitigate Lipitor’s Slide
January 30, 2013
category Pharmaceuticals
from Trefis
Life aided by buyout talk; Vertex sinks on losses
January 30, 2013
Life Technologies shares are aided by talk of a buyout while Vertex Pharmaceuticals falls when its fourth-quarter loss is wider than expected. Read More
category TMO , Earnings , Biotechnology , and 22 more.
from MarketWatch
UPDATE 1-AbbVie issues 2013 forecast in line with Street estimates
January 30, 2013
Jan 30 (Reuters) - AbbVie, the pharmaceuticals business spun off earlier this month by Abbott Laboratories , forecast 2013 earnings in line with Wall Street forecasts. Read More
category companyNews
from Reuters: Company News
UCO, UPRO: Big ETF Outflows
January 28, 2013
Turning today to week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, the largest outflow was seen in the Proshares Ultra DJ-UBS Crude Oil (UCO), which shed... Read More
category ETFs
from ETF Channel
Shabby Reporting And Questionable Prospects At Abbott Labs (ABT, COV, MJN, JNJ)
January 28, 2013
Poor reporting and weak margins undermine the potential of Abbott. Read More
from Investopedia Advisor Commentary
Roche Holdings’ Earnings: Oncology Drugs, Diagnostics To Drive Growth
January 28, 2013
category Pharmaceuticals
from Trefis
Watch for Shares of Abbott Laboratories (ABT) to Approach Resistance at $33.02
January 28, 2013
from Comtex SmarTrend® News Briefs
Is AbbVie's Overdependence on Humira a Long-Term Problem?
January 28, 2013
Recently, Abbott Laboratories broke itself up into two parts: Abbott, a diversified medical products company and AbbVie, a research based pharmaceutical company. The jewel of the new pharma company is... Read More
category NYSE:ABBV , NYSE:ABT
from Forbes Real Time
Kimberly Clark Continues To Clean Up In Emerging Markets
January 28, 2013
category Pharmaceuticals , Beauty & Personal Care , Retail & Household Products
from Trefis
Pfizer Q4 Earnings Preview: Pain From Patent Expirations To Continue
January 28, 2013
category Pharmaceuticals
from Trefis
Boston Scientific Q4 Earnings Preview: What We Are Watching
January 25, 2013
category Pharmaceuticals , Medical Devices & Supplies
from Trefis
Abbott’s Humira, Androgel and Nutritional Business Lift Results
January 24, 2013
category Pharmaceuticals , Medical Devices & Supplies
from Trefis
UPDATE 3-Abbott results bode well for spun-off AbbVie
January 23, 2013
Jan 23 (Reuters) - AbbVie Inc, the new branded pharmaceuticals company spun off by Abbott Laboratories Inc , is off to a good start, judging by fourth-quarter sales of arthritis drug Humira and other... Read More
category companyNews
from Reuters: Company News
Apple Preview: Can Tech Giant Repair 'Cracked Halo'?
January 23, 2013
Earnings beats from Google and IBM boosted Apple stock on Wednesday, as traders bet the one-time darling could regain some of its luster when it reports earnings after the bell. Apple earnings are... Read More
category Siemens AG , Coca Cola Co , Advanced Micro Devices Inc , and 36 more.
from CNBC.com News
A few wild stock swings in health earnings
January 23, 2013
A handful of health-care companies see wild swings in their stocks amid a slew of earnings reports, while others barely move the needle. Read More
category Earnings , SYK , Biotechnology , and 19 more.
from MarketWatch
'New' Abbott Labs Enters Emerging Markets Free Of Obamacare, European Austerity
January 23, 2013
The new Abbott Laboratories (ABT) begins its 125th year focused on sales of medical devices, established generic drugs, diagnostic tests and nutritionals with an eye on emerging markets led by Russia,... Read More
category NYSE:PFE , NYSE:ABT
from Forbes Real Time
Stock Upgrades: Stock Up on Costco
January 23, 2013
As the moguls of business assemble this morning on the moguls of Davos there is no sign that stocks are about to slide downhill any time soon. (With the possible exception of Alpine Global Dynamic... Read More
from Minyanville Headlines
Abbott Labs Q4 Sales Rose +4.4%; Profits Down -35% (ABT)
January 23, 2013
On Wednesday pharmaceutical and health care products manufacturer Abbott Laboratories (ABT) saw a steep drop in fourth quarter profits. However, adjusted earnings slightly exceeded Wall Street... Read More
category abbott , abt , Dividend Stocks , and 1 more.
from Dividend Daily
Futures Mixed On Q4 Reports; Google, Cree Move Higher
January 23, 2013
Stock futures struggled in mixed territory ahead of Wednesday's open as a barrage of earnings reports powered some steep, premarket reactions. Dow futures traded down 11 points, but held just above... Read More
category Intraday Updates
from Investor's Business Daily - Investing RSS
BRIEF-Abbott Labs up in premarket after Q4 results, outlook
January 23, 2013
NEW YORK, Jan 23 (Reuters) - Abbott Laboratories : * Abbott Labs up 1.2 percent to $33.29 in premarket after Q4 results, outlook Read More
category companyNews
from Reuters: Company News
Abbott Laboratories (ABT) Tops Q4 EPS by 1c
January 23, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8024795 for the full story. Read More
from StreetInsider.com News Articles
Benzinga Market Primer: Wednesday, January 23
January 23, 2013
Futures Flat on Earnings, Eye House Vote U.S. equity futures were near unchanged overnight despite mostly positive earnings from large tech and transportation companies. Also, stocks await a vote in... Read More
category Spain GDP , Earnings , Benzinga , and 57 more.
from Latest Articles from Benzinga.com
Big earnings on Wednesday: Apple, McDonald’s
January 23, 2013
Among the companies whose shares are expected to see active trade in Wednesday’s session are McDonald’s and United Technologies as well as Apple and Netflix, both of which report quarterly financial... Read More
category MSI , Earnings , MCD , and 31 more.
from MarketWatch
Pharma Business & Synthes Drive Johnson & Johnson’s Growth
January 23, 2013
category Pharmaceuticals , Medical Devices & Supplies
from Trefis
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here